Clinical Trial Update: Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ribavirin loading dose/priming and concentration targeting for Hepatitis C genotype 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Göteborg University | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED